Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpwin Grp Regulatory News (EPWN)

  • This share is currently suspended. It was suspended at a price of 119.50
  • There is currently no data for EPWN

Form 8 (OPD) - Epwin Group plc

13 Aug 2025 11:43

RNS Number : 1970V
Epwin Group PLC
13 August 2025
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Epwin Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Epwin Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

13 August 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares 0.05p

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Holdings of ordinary shares by the directors of Epwin Group plc ("Epwin" or the "Company") and their close relatives:

 

Name

Number of Epwin ordinary shares held

% of total issued share capital

Jonathan Bednall and spouse

426,183

0.31

Christopher Empson and close relatives

369,393

0.27

Shaun Smith and spouse

10,000

0.00

Stephen Harrison

10,000

0.00

 

b) The directors of the Company have the following rights to subscribe for the following relevant Epwin Group plc securities:

 

Name

Date of grant

Type of grant

Vesting Date

Expiry Date

Exercise price (p)

No. of options outstanding*

Jonathan Bednall

06/05/2022

LTIP**

06/05/2025

06/05/2032

0.05

172,484

Jonathan Bednall

25/04/2023

LTIP**

25/05/2026

25/05/2033

0.05

231,395

Jonathan Bednall

23/04/2024

LTIP**

23/04/2027

23/04/2034

0.05

195,670

Jonathan Bednall

06/05/2025

LTIP**

06/05/2028

06/05/2035

0.05

182,798

Christopher Empson

06/05/2022

LTIP**

06/05/2025

06/05/2032

0.05

124,188

Christopher Empson

25/04/2023

LTIP**

25/05/2026

25/05/2033

0.05

161,976

Christopher Empson

23/04/2024

LTIP**

23/04/2026

23/04/2034

0.05

136,969

Christopher Empson

06/05/2025

LTIP**

06/05/2028

06/05/2035

0.05

134,989

 

* Number of options outstanding includes accrued entitlement to dividends paid during the vesting period

 

** Options relate to Epwin Group plc's Long Term Incentive Plan (LTIP) awarded by the remuneration committee. The LTIP awards are subject to performance criteria as disclosed within the Company's Annual Report for the relevant year of the awards

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

13 August 2025

Contact name:

Andrew Rutter

Telephone number:

0121 746 3700

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBXLFFEVLZBBF
Date   Source Headline
7th Dec 20238:28 amRNSTransaction in Own Shares
5th Dec 202310:28 amRNSTransaction in Own Shares
4th Dec 20235:16 pmRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
28th Nov 20234:05 pmRNSTransaction in Own Shares
27th Nov 20234:47 pmRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTrading Update and Share Buyback
10th Nov 20232:00 pmRNSDirector/PDMR Shareholding
27th Oct 20233:00 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSHalf-year results
8th Aug 20231:56 pmRNSCancellation of Treasury Shares
7th Aug 20239:35 amRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSHalf-year trading update and notice of results
11th Jul 202310:39 amRNSBlock listing Interim Review
6th Jul 20234:15 pmRNSTotal Voting Rights
23rd May 20233:01 pmRNSResults of Annual General Meeting
23rd May 20237:00 amRNSAGM Trading Update
9th May 20233:38 pmRNSDirector/PDMR Shareholding
25th Apr 20235:57 pmRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSAnnual Report and Accounts 2022 and 2023 AGM
20th Apr 20231:12 pmRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
10th Feb 20234:31 pmRNSHolding(s) in Company
31st Jan 20232:12 pmRNSHolding(s) in Company
25th Jan 20237:00 amRNSYear-end trading update and notice of results
11th Jan 20237:00 amRNSBlock Listing Six Monthly Return
2nd Nov 20227:00 amRNSAppointment of Independent Non-Executive Director
14th Sep 20227:00 amRNSHalf year results
12th Sep 20227:00 amRNSAcquisition of Poly-Pure Ltd
28th Jul 20227:00 amRNSHalf-year trading update and notice of results
11th Jul 202210:45 amRNSBlock Listing Six Monthly Return
17th Jun 20223:15 pmRNSGrant of Options under SAYE Scheme
1st Jun 20223:30 pmRNSDirectorate Change
24th May 20222:18 pmRNSResult of AGM
24th May 20227:00 amRNSAGM Trading Update
6th May 20224:41 pmRNSDirector/PDMR Shareholding
27th Apr 20224:20 pmRNSAnnual Report and Accounts 2021 and 2022 AGM
14th Apr 20221:51 pmRNSDirector/PDMR Shareholding
6th Apr 20227:00 amRNSFinal results for the year ended 31 December 2021
14th Mar 20227:00 amEQSEpwin Group (EPWN): The best is yet to come
3rd Mar 20227:00 amRNSDirectorate Change
26th Jan 20224:58 pmRNSHolding(s) in Company
20th Jan 20227:00 amRNSYear-end trading update and notice of results
10th Jan 20227:00 amRNSBlock listing Six Monthly Return
9th Dec 20217:00 amRNSAppointment of Independent Non-Executive Director
30th Sep 20217:00 amRNSChange of Auditor
15th Sep 20217:00 amRNSHalf year results
3rd Sep 20213:30 pmRNSHolding(s) in Company
1st Sep 20217:00 amRNSTotal Voting Rights
28th Jul 20217:00 amRNSHalf-year Trading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.